Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. reported revenue of $44.56B for the fiscal year ended Dec 31, 2025, up 3.9% from $42.88B the year before. Net income was $6.70B, a net margin of 15.0% (prior year: $6.33B). At the end of that fiscal year the company reported total assets of $110.34B and shareholders' equity of $53.41B.
Revenue
$44.56B
+3.9% vs prior year
Net income
$6.70B
Net margin 15.0%
Diluted EPS
$17.74
USD per share
Total assets
$110.34B
At Dec 31, 2025
Equity
$53.41B
At Dec 31, 2025
Shares outstanding
371M
As of Sep 26, 2026
Explore Thermo Fisher Scientific Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 30, 2026
- 10-QFiled Jul 31, 2026
- 10-QFiled May 1, 2026
- 10-KFiled Feb 26, 2026
- 10-QFiled Oct 31, 2025
- 10-QFiled Aug 1, 2025
Compare Thermo Fisher Scientific Inc.
- DHRTMO vs DHR
Source: SEC EDGAR XBRL company facts for CIK 97745 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.